B.A., University of Pennsylvania; J.D., Harvard
Professor Wolfman re-joined the Georgetown Law faculty in 2016 as the Director of the new full-time, semester-long Appellate Clinic. He was previously a Professor of the Practice of Law and Co-Director of Stanford Law School’s Supreme Court Litigation Clinic. Before that, from 2009 to 2014, Professor Wolfman served as Director of the Civil Rights section of Georgetown Law’s Institute for Public Representation, a student clinic that handles complex trial court and appellate litigation focused on civil rights and other public-interest litigation. While at Georgetown, he also taught the standard doctrinal course on Federal Courts and the Federal System and a course on appellate courts. Before Georgetown, he spent nearly 20 years at the national public interest law firm Public Citizen Litigation Group, serving the last five years as the Group’s Director. Earlier in his career, he conducted trial and appellate litigation as a staff lawyer at a rural poverty law program in Arkansas. Professor Wolfman has handled a broad range of litigation, including cases involving health and safety regulation, class action governance, court-access issues, federal preemption, consumer law, public-benefits law, and government transparency. He has argued six cases before the Supreme Court (winning five), and he has litigated hundreds of cases before federal and state appellate and trial courts around the country. He directed Public Citizen’s Supreme Court Assistance Project, which helps “underdog” public-interest clients litigate before the U.S. Supreme Court. He has testified before Congress and federal rules committees on a range of issues, and he was an Advisor to the American Law Institute’s Principles of the Law of Aggregate Litigation. Since 2004, he has taught an intensive Appellate Courts Workshop during the January Term at Harvard Law School. Professor Wolfman has authored articles on a variety of subjects, often on the intersection of state tort law and federal preemption doctrine and on class actions.
"DOJ opposes Another Class Deal, Another Court Ignores It", coverage in Bloomberg Law, August 9, 2018 featuring Professor Brian Wolfman.
"SCOTUS to Review Revival of Merck Fosamax Suits", coverage in Bloomberg Law, June 28, 2018, quoting Professor Brian Wolfman.
"Are we asking judicial nominees to reveal too much? Experts say yes," coverage by McClatchy, May 8, 2018, quoting Associate Professor Brian Wolfman.
"SEC Seeks Divided Argument In High Court Dispute Over ALJs," by Mealey's Litigation Report: Emerging Securities Pleadings, April 16, 2018, with a reference to Director Brian Wolfman, Appellate Courts Immersion Clinic.